Heteroaryl antagonists of prostaglandin D2 receptors
US8049015B2 · kind B2 · utility
3Cited by
9References
36Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 28, 2009 |
| Grant date | Nov 1, 2011 |
| Priority date | — |
| Expiry date | Nov 9, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions that include the compounds described herein, and methods of using such antagonists of PGD2 receptors, alone or in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.